Catalyst Wire Dossier Catalyst Wire Dossier

Tritanrix™-HepB/Hib2.5

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tritanrix™-HepB/Hib2.5, covering 2016-09-09 to 2016-09-09. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity, Safety & Reactogenicity of GSK Vaccine Tritanrix™-HepB/Hib2.5 Compared to GSK Vaccine Tritanrix™-HepB/Hiberix™ [Phase 2]

See pricing